Cargando…

A Comparison of Operational Definitions for Mild Cognitive Impairment

BACKGROUND: Consideration of many tests from different cognitive domains in defining mild cognitive impairment (MCI) is clinical routine, but guidelines for a neuropsychological operationalization of MCI are lacking. OBJECTIVE: Among different operational MCI criteria, to identify those which are be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polcher, Alexandra, Wolfsgruber, Steffen, Peters, Oliver, Frölich, Lutz, Wiltfang, Jens, Kornhuber, Johannes, Hüll, Michael, Rüther, Eckart, Lewczuk, Piotr, Maier, Wolfgang, Jessen, Frank, Wagner, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484125/ https://www.ncbi.nlm.nih.gov/pubmed/35811516 http://dx.doi.org/10.3233/JAD-215548

Ejemplares similares

Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment
por: Wolfsgruber, Steffen, et al.
Publicado: (2014)

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
por: Frölich, Lutz, et al.
Publicado: (2017)

Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease
por: Peters, Oliver, et al.
Publicado: (2015)

Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network
por: Benson, Gloria S., et al.
Publicado: (2022)

Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments
por: Ophey, Anja, et al.
Publicado: (2021)

Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer’s Disease Dementia via Lead-Lag Analysis
por: Fuentes, Manuel, et al.
Publicado: (2020)

Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study
por: Morgen, Katrin, et al.
Publicado: (2015)

Distributions of Aβ42 and Aβ42/40 in the Cerebrospinal Fluid in View of the Probability Theory
por: Lewczuk, Piotr, et al.
Publicado: (2021)

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
por: Bibl, Mirko, et al.
Publicado: (2006)

Advance directives for future dementia can be modified by a brief video presentation on dementia care: An experimental study
por: Volhard, Theresia, et al.
Publicado: (2018)

PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
por: Kleineidam, Luca, et al.
Publicado: (2020)

Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
por: Lacour, A, et al.
Publicado: (2017)

Phagocytosis and LPS alter the maturation state of β-amyloid precursor protein and induce different Aβ peptide release signatures in human mononuclear phagocytes
por: Spitzer, Philipp, et al.
Publicado: (2010)

Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes
por: Espinosa, Ana, et al.
Publicado: (2018)

The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes
por: Oberstein, Timo Jan, et al.
Publicado: (2021)

Combined Analysis of CSF Tau, Aβ42, Aβ1–42% and Aβ1–40(ox)% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia
por: Bibl, Mirko, et al.
Publicado: (2010)

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012)

Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
por: Baldeiras, Inês, et al.
Publicado: (2019)

Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment
por: Bainbridge, Wilma A., et al.
Publicado: (2019)

Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer’s Dementia in the Oldest Old
por: Melo van Lent, Debora, et al.
Publicado: (2021)

Clinical significance of fluid biomarkers in Alzheimer’s Disease
por: Lewczuk, Piotr, et al.
Publicado: (2020)

The Clinical Use of Alzheimer’s Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer’s Disease Consortium Survey
por: Caprioglio, Camilla, et al.
Publicado: (2022)

Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study
por: Miebach, Lisa, et al.
Publicado: (2019)

Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer’s disease spectrum
por: Amaefule, Chimezie O., et al.
Publicado: (2020)

Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial
por: Maier, Franziska, et al.
Publicado: (2020)

Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study
por: Sannemann, Lena, et al.
Publicado: (2020)

A combined miRNA–piRNA signature to detect Alzheimer’s disease
por: Jain, Gaurav, et al.
Publicado: (2019)

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
por: Mroczko, Barbara, et al.
Publicado: (2018)

Alzheimer’s Disease—Biochemical and Psychological Background for Diagnosis and Treatment
por: Beata, Bocwinska-Kiluk, et al.
Publicado: (2023)

Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
por: Dulewicz, Maciej, et al.
Publicado: (2022)

A combined electrophysiological and morphological examination of episodic memory decline in amnestic mild cognitive impairment
por: Hoppstädter, Michael, et al.
Publicado: (2013)

Low Serum Vitamin D Status Is Associated with Incident Alzheimer’s Dementia in the Oldest Old
por: Melo van Lent, Debora, et al.
Publicado: (2022)

Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)
por: Jessen, Frank, et al.
Publicado: (2018)

Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples
por: Wolfsgruber, Steffen, et al.
Publicado: (2019)

Perfusion Imaging with SPECT in the Era of Pathophysiology-Based Biomarkers for Alzheimer's Disease
por: Weih, Markus, et al.
Publicado: (2010)

Using Voxel-Based Morphometry to Examine the Relationship between Regional Brain Volumes and Memory Performance in Amnestic Mild Cognitive Impairment
por: Meyer, Patric, et al.
Publicado: (2013)

Cognitive performance before and after the onset of subjective cognitive decline in old age
por: Koppara, Alexander, et al.
Publicado: (2015)

Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer’s disease
por: Frölich, Lutz, et al.
Publicado: (2019)

Persistence of neuropsychiatric symptoms and dementia prognostication: A comparison of three operational case definitions of mild behavioral impairment
por: Guan, Dylan X., et al.
Publicado: (2023)

The ‘Operational’ Definition of Self-Control
por: Gillebaart, Marleen
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iaug20kf93i32bv30os1kb43t5